OBSOLETE: Infantile non-syndromic cataract Advocacy Hub | UniteRare

Regulatory Watchboard

1 event

Mar 2014

HEMANGEOL: FDA approved

Treatment of proliferating infantile hemangioma requiring systemic therapy.

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for OBSOLETE: Infantile non-syndromic cataract.
Check the disease page for updates →

No active clinical trials currently recruiting for OBSOLETE: Infantile non-syndromic cataract.
Search all trials →

No recent news articles indexed yet for OBSOLETE: Infantile non-syndromic cataract.
Search PubMed for OBSOLETE: Infantile non-syndromic cataract →

No specialists currently listed for OBSOLETE: Infantile non-syndromic cataract.

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants